Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Xinidamine

Copy Product Info
😃Good
Catalog No. T35182Cas No. 50264-78-3
Alias Xinidaminum, Xinidamino, BRN 0891979

Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.

Xinidamine

Xinidamine

Copy Product Info
😃Good
Purity: 98.12%
Catalog No. T35182Alias Xinidaminum, Xinidamino, BRN 0891979Cas No. 50264-78-3
Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$147In StockIn Stock
5 mg$348In StockIn Stock
10 mg$475In StockIn Stock
25 mg$667In StockIn Stock
50 mg$826In StockIn Stock
100 mg$1,050In StockIn Stock
200 mg$1,370-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.12%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Xinidamine AI Summary
Xinidamine has demonstrated significant antispermatogenic activity in Long-Evans rats following a single administration. The reduction in testes weight served as the primary measure of bioactivity, with a median effective dose (MED) identified at 101.0 mg/kg after a period of 5 days..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.
Targets&IC50
Proliferation (PWR-1E cells):4 μM
SynonymsXinidaminum, Xinidamino, BRN 0891979
Chemical Properties
Molecular Weight280.32
FormulaC17H16N2O2
Cas No.50264-78-3
SmilesC(N1C=2C(C(C(O)=O)=N1)=CC=CC2)C3=C(C)C=C(C)C=C3
Relative Density.1.22g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (178.37 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.5674 mL17.8368 mL35.6735 mL178.3676 mL
5 mM0.7135 mL3.5674 mL7.1347 mL35.6735 mL
10 mM0.3567 mL1.7837 mL3.5674 mL17.8368 mL
20 mM0.1784 mL0.8918 mL1.7837 mL8.9184 mL
50 mM0.0713 mL0.3567 mL0.7135 mL3.5674 mL
100 mM0.0357 mL0.1784 mL0.3567 mL1.7837 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Xinidamine | purchase Xinidamine | Xinidamine cost | order Xinidamine | Xinidamine chemical structure | Xinidamine formula | Xinidamine molecular weight